Cancer cell lines (CCLs) as important model systems play critical roles in cancer researches. The misidentification and contamination of CCLs are serious problems, leading to unreliable results and waste of resources. Current methods for CCL authentication are mainly based on the CCL-specific genetic polymorphisms, whereas no method is available for CCL authentication using gene expression profiles. Here, we developed a novel method and homonymic web server (CCLA, Cancer Cell Line Authentication, http://bioinfo.life.hust.edu.cn/web/CCLA/) to authenticate 1,291 human CCLs of 28 tissues using gene expression profiles. CCLA curated CCL-specific gene signatures and employed machine learning methods to measure overall similarities and distances between the query sample and each reference CCL.
CCLs with drug treatment). Besides, CCLs with gene over-expression (GSE61692 1 6 and GSE23655) or gene knockout (GSE101966) treatments were all correctly 1 7 authenticated as the original ones by CCLA (Table 1 , Supplementary Table S1 ).
8
Furthermore, we also assessed the power of CCLA on the well-known 1 9
misidentified CCLs, such as the MDA-MB-435 cell line, which was not a human 2 0 breast cancer cell line but had been proved as M14 melanoma cell line by ATCC and 2 1 several laboratories (Christgen and Lehmann 2007; Lacroix 2009 ; Prasad and Gopalan 2 2 7 2015). Interesting, the authentication for 8 MDA-MB-435 cell line samples 1 (GSE128624) by CCLA showed that all of them were melanoma cell lines 2 ( Supplementary Table S3 ), implying the misidentification of MD-AMB-435 cell line 3 was a long-time event and CCLA could serve as a valuable tool to benefit the 4 reproducibility of scientific data and results based on the available expression data.
5
Comparison with other approaches 6 Although a few methods (e.g., CeL-ID and Fasterius' method) could utilize 7 RNA-Seq data to authenticate CCLs (Fasterius et al. 2017; Mohammad et al. 2019 ), 8 their core algorithms retrieved genomic polymorphism of samples from RNA-Seq 9 reads (not the expression profiles) to match CCL-specific SNPs and could not be 1 0 applied on microarray data. Meanwhile, these methods just stated a pipeline and did not 1 1 provide any mature software (package, tool or online server) and important parameters 1 2 (e.g. the version of used tools, the match pattern, the reference SNPs of CCLs, and the 1 3 threshold etc.) in their publications, which made it very difficult to reproduce their 1 4
results. Thus, we just compared the authentication results of CCLA and CeL-ID based 1 5
on the same RNA-seq data used by CeL-ID (Table 2) .
6
Two datasets containing 20 samples (12 samples of MCF7 CCL from GSE23655, CCLA is the only available tool and online web server to provide mature and 8 convenient service for CCL authentication using gene expression profiles.
9
Website interface of CCLA 1 0
For the convenient application of CCLA by users, we developed a homonymic web 1 1 server to provide free service of 1,291 CCLs authentication ( Figure 3 ). Users could 1 2 easily authenticate and assess their interested CCLs using gene expression data. CCLA 1 3 accepts a NCBI GEO accession of microarray data or unfiltered gene expression matrix 1 4 ( Figure 3A ), whose rows represent the normalized expression value for genes (FPKM, 
The authentication of cell lines is a key factor for the reliability of biomedical 2 0 researches, which is required for the grant application and manuscript publication under specific conditions, which lacked enough genomic polymorphisms for CCL 2 0
authentication (e.g. microarray and RNA-Seq data). Our CCLA implemented GSVA 2 1 algorithm to calculate a robust signal score matrix for CCLs, and then employed a good sensitivity and accuracy on distinguishing CCLs from the same tissue origin 1 5
( Figure 2D and Supplementary Table S2 ). In this way, CCLA is an essential tool to 1 6
integrate metadata and ensure the reproducibility and reliability of results from cancer 1 7 research using CCLs of previous studies.
8
Although CCLA showed a high accuracy for the authentication of 1,291 CCLs, the 
9
The authentication of CCLs is an essential issue to avoid fake data and ensure the 1 1 Furthermore, we examined the integrity of information for all the CCLs above.
2
Briefly, all the introductions of reference CCLs were retrieved using an in-house "web 1 3 crawler" script programmed by the python language and its libs (e.g. urllib,
4
BeautifulSoup, and requests etc.). First, CCLs with a similar character string (e.g.
5
"HCT 116" or "HCT116" or "HCT-116" or "HCT_116", but not limited in this style) 1 6 and the same origin (e.g. from the colon or large-intestine etc.) were deemed as the 1 7 same kind of a CCL with different aliases. Then CCLs with similar origins but 1 8
large-distance of their names (20%, e.g., the character difference between SW1417 1 9
and SW1463, not limited in this situation) were carefully checked and manually 2 0 examined from the webpages of the resources. In addition, when a CCL was stored in 2 1 1 5 more than one source, the priority of its gene expression profile as a reference in 1 CCLA was ranked by the following order (CCLE > GDSC > E- MTAB-2706 
9
Curation of signature genes for CCLs 1 0
First, the gene signatures of each CCL were retrieved from literature mining, 1 1 resource collection and de novo detection processes: 1) Literature mining from 1 2 publications. In this process, we used several key words (e.g., "maker gene", 1 3 "specifically expressed gene (SEG)", and "highly expressed gene" etc.) in the 1 4
PubMed database to retrieve candidate signature genes for corresponding CCLs; 2) 1 5
Resource collection. Two databases Harmonizome and SEGreg (Rouillard et al. 2016;  1 6 Tang et al. 2018) were the main resources to collect the signature genes. In
7
Harmonizome, those candidate signature genes with a score > 1 were used, which 1 8
indicates that the gene has a strong positive gene-CCL association. In SEGreg 1 9
database, genes with the tag "high" in the corresponding CCL was deemed as gene expression profiles of 1,471 reference CCLs, and the output SEGs were acted as 1 candidate signature genes as well.
2
Second, candidate signature genes from the above three processes were integrated 3 to explore putative signature genes by the following two steps: 1) For CCLs from the 4 same tissue (or organ), we calculated and adjusted the ratio of tissue-specific genes to 5 candidate signature genes. For example, if the ratios of tissue-specific genes (with the 6 number of 30) were more than 40% in 5 CCLs, we randomly assigned the same 7 number of tissue-specific genes (e.g., the number is 30/5 = 6 in this case, allowed 1/5 8 = 20% repetition) to the 5 CCLs; 2) For CCLs with similar candidate signature genes,
9
we implemented the same operation as the step 1. Furthermore, we measured the 1 0 reliability of signature genes in reference CCLs by examining their expression levels.
1
After the above processes, the retained genes were considered as putative signature 1 2
genes. Finally, 180 out of 1,471 CCLs that did not have enough signature genes (less 1 3 than 50) were dropped, and the rest 1,291 reference CCLs were kept for further 1 4
analyses.
5

Signature calculation and model construction for CCLs 1 6
To avoid the bias and technical variability of gene expression caused by the noise, 1 7 different quantile normalization methods, and various experiment treatments, ssGSEA 1 8
algorithm was implemented to calculate the enrichment scores of signature genes for 1 9 each CCL, which could serve as robust expression features compared with the raw gene 2 0 expression profiles (Figure 1) . Thus, the raw expression profiles of reference CCLs 2 1 have been represented by ssGSEA scores of signature genes sets, and each CCL has the 2 2 1 7 same 1,291 signatures, whose expression values are ssGSEA scores. Next, we 1 constructed a 1,291 x 1,291 signature matrix for the reference CCLs, in which, each 2 row is the corresponding signature values in 1,291 CCLs, and columns represent CCLs.
3 Furthermore, t-distributed stochastic neighbor embedding (t-SNE) algorithm was 4 used for the classification and clustering of reference CCLs based on their signatures 5 (parameters: dims = 3, perplexity = 50, max_iter = 5000, theta = 0, pca = TRUE), and 6 three groups were obtained. Subsequently, we employed the random forest (RF) 7 algorithm to extract features from reference CCLs with their group labels determined 8 by t-SNE (the importance of each feature was represented in the Supplementary Table   9 S5), and then built a prediction model that would been applied to estimate the potential 1 0 group for the query CCL (Figure 1 ).
1 1
CCL authentication 1 2
In order to accurately authenticate CCLs, CCLA calculates the ssGSEA score of (Table 1) .
6
We employed the following criteria to judge a successful authentication in CCLA: identified as the melanoma origin, we deemed this authentication was a correct case.
1 6 1 7 
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